Related Experiment Video
Updated: Jan 21, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Global Pediatric Regulations: An Overview.
Priya M Gadge1, Prathmesh P Kenjale2, Varsha B Pokharkar2
11 Department of Drug Regulatory Affairs, BVDU Poona College of Pharmacy, Pune, Maharashtra, India.
Pediatric drug development requires specific regulations due to children's unique physiology. Current pediatric drug laws need enhancement to ensure patient safety and efficacy, addressing "therapeutic orphans".
Area of Science:
- Pharmacology and Regulatory Science
- Pediatric Drug Development
- Clinical Trial Regulations
Background:
- Adult physiological conditions differ significantly from children's, necessitating distinct drug dosage regimens.
- Children exhibit unique pharmacokinetic and pharmacodynamic characteristics, requiring reconfirmation of drug effects.
- Many drugs used in pediatric care are considered "therapeutic orphans" due to development challenges and insufficient data.
Purpose of the Study:
- To review current pediatric regulatory requirements for drug safety and efficacy.
- To identify necessary regulatory efforts to improve pediatric drug development.
- To highlight the importance of region-specific regulatory bodies in pediatric drug administration.
Main Methods:
- Review of existing pediatric drug regulatory frameworks.
- Analysis of the challenges in pediatric clinical trials.
- Examination of regulatory efforts and their impact on pediatric patient safety.
Main Results:
- Current pediatric drug regulations are insufficient, leading to a lack of data for many pediatric medications.
- The number of clinical trials conducted in children remains inadequate.
- Significant focus is needed on laws and regulations governing pediatric drug development.
Conclusions:
- Enhanced pediatric regulatory requirements are crucial for ensuring drug safety and efficacy in children.
- Addressing the "therapeutic orphan" status requires dedicated regulatory strategies and increased clinical trials.
- Collaboration with various regional regulatory bodies is essential for global pediatric drug development.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Global Climate Change
Epigenetic Regulation
GTPases and their Regulation
Large G-proteins,...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Introduction to Global Positioning System

